Annual Retained Earnings
-$199.14 M
-$6.58 M-3.42%
31 December 2022
Summary:
Nymox Pharmaceutical annual retained earnings is currently -$199.14 million, with the most recent change of -$6.58 million (-3.42%) on 31 December 2022. During the last 3 years, it has fallen by -$19.11 million (-10.62%).NYMX Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Retained Earnings
-$200.53 M
-$1.39 M-0.70%
31 March 2023
Summary:
Nymox Pharmaceutical quarterly retained earnings is currently -$200.53 million, with the most recent change of -$1.39 million (-0.70%) on 31 March 2023.NYMX Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NYMX Retained Earnings Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | -10.6% | -5.7% |
| 5 y5 years | -28.4% | -21.1% |
NYMX Retained Earnings High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | ||||
| 5 y | 5 years | ||||
| alltime | all time | +2557.8% | +3358.2% |
Nymox Pharmaceutical Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | - | -$200.53 M(+0.7%) |
| Dec 2022 | -$199.14 M(+3.4%) | -$199.14 M(+0.7%) |
| Sept 2022 | - | -$197.80 M(+0.8%) |
| June 2022 | - | -$196.31 M(-0.7%) |
| Mar 2022 | - | -$197.65 M(+2.6%) |
| Dec 2021 | -$192.56 M(+7.0%) | -$192.56 M(+1.5%) |
| Sept 2021 | - | -$189.75 M(+1.8%) |
| June 2021 | - | -$186.45 M(+2.2%) |
| Mar 2021 | - | -$182.46 M(+1.4%) |
| Dec 2020 | -$180.03 M(+7.0%) | -$180.03 M(+1.1%) |
| Sept 2020 | - | -$178.00 M(+2.4%) |
| June 2020 | - | -$173.84 M(+1.7%) |
| Mar 2020 | - | -$170.90 M(+1.6%) |
| Dec 2019 | -$168.29 M(+8.5%) | -$168.29 M(+1.6%) |
| Sept 2019 | - | -$165.60 M(+1.5%) |
| June 2019 | - | -$163.14 M(+3.3%) |
| Mar 2019 | - | -$158.00 M(+1.9%) |
| Dec 2018 | -$155.11 M(+7.3%) | -$155.11 M(+1.8%) |
| Sept 2018 | - | -$152.39 M(+1.9%) |
| June 2018 | - | -$149.60 M(+1.6%) |
| Mar 2018 | - | -$147.18 M(+1.8%) |
| Dec 2017 | -$144.52 M(+10.2%) | -$144.52 M(+2.4%) |
| Sept 2017 | - | -$141.19 M(+3.4%) |
| June 2017 | - | -$136.61 M(+2.6%) |
| Mar 2017 | - | -$133.10 M(+1.5%) |
| Dec 2016 | -$131.09 M(+11.1%) | -$131.09 M(+2.2%) |
| Sept 2016 | - | -$128.26 M(+2.5%) |
| June 2016 | - | -$125.13 M(+3.2%) |
| Mar 2016 | - | -$121.31 M(+2.8%) |
| Dec 2015 | -$117.98 M(+17.9%) | -$117.98 M(+3.6%) |
| Sept 2015 | - | -$113.87 M(-6.5%) |
| June 2015 | - | -$121.79 M(+23.7%) |
| Mar 2015 | - | -$98.46 M(-1.6%) |
| Dec 2014 | -$100.04 M(+5.2%) | -$100.04 M(+0.6%) |
| Sept 2014 | - | -$99.47 M(+0.8%) |
| June 2014 | - | -$98.69 M(+0.9%) |
| Mar 2014 | - | -$97.80 M(+2.8%) |
| Dec 2013 | -$95.14 M(+5.8%) | -$95.14 M(+1.5%) |
| Sept 2013 | - | -$93.76 M(+1.2%) |
| June 2013 | - | -$92.64 M(+1.7%) |
| Mar 2013 | - | -$91.11 M(+1.3%) |
| Dec 2012 | -$89.91 M(+9.5%) | -$89.91 M(+3.3%) |
| Sept 2012 | - | -$87.02 M(+1.5%) |
| June 2012 | - | -$85.72 M(+2.1%) |
| Mar 2012 | - | -$83.95 M(+2.2%) |
| Dec 2011 | -$82.11 M(+13.7%) | -$82.11 M(+2.3%) |
| Sept 2011 | - | -$80.25 M(+2.1%) |
| June 2011 | - | -$78.58 M(+2.5%) |
| Mar 2011 | - | -$76.63 M(+6.1%) |
| Dec 2010 | -$72.20 M | -$72.20 M(+4.8%) |
| Sept 2010 | - | -$68.87 M(+2.7%) |
| June 2010 | - | -$67.04 M(+2.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2010 | - | -$65.25 M(+2.1%) |
| Dec 2009 | -$63.90 M(+9.1%) | -$63.90 M(+2.5%) |
| Sept 2009 | - | -$62.32 M(+2.4%) |
| June 2009 | - | -$60.88 M(+2.1%) |
| Mar 2009 | - | -$59.60 M(+1.8%) |
| Dec 2008 | -$58.56 M(+16.0%) | -$58.56 M(+7.8%) |
| Sept 2008 | - | -$54.33 M(+2.7%) |
| June 2008 | - | -$52.93 M(+2.3%) |
| Mar 2008 | - | -$51.72 M(+2.5%) |
| Dec 2007 | -$50.47 M(+12.4%) | -$50.47 M(+2.7%) |
| Sept 2007 | - | -$49.16 M(+3.2%) |
| June 2007 | - | -$47.63 M(+3.3%) |
| Mar 2007 | - | -$46.09 M(+2.7%) |
| Dec 2006 | -$44.88 M(+13.0%) | -$44.88 M(+2.9%) |
| Sept 2006 | - | -$43.61 M(+3.0%) |
| June 2006 | - | -$42.34 M(+3.4%) |
| Mar 2006 | - | -$40.94 M(+3.1%) |
| Dec 2005 | -$39.70 M(+10.4%) | -$39.70 M(+2.3%) |
| Sept 2005 | - | -$38.79 M(+2.3%) |
| June 2005 | - | -$37.91 M(+2.7%) |
| Mar 2005 | - | -$36.92 M(+2.7%) |
| Dec 2004 | -$35.95 M(+14.3%) | -$35.95 M(+3.0%) |
| Sept 2004 | - | -$34.92 M(+2.0%) |
| June 2004 | - | -$34.23 M(+3.6%) |
| Mar 2004 | - | -$33.04 M(+5.1%) |
| Dec 2003 | -$31.45 M(+17.6%) | -$31.45 M(+5.7%) |
| Sept 2003 | - | -$29.74 M(+2.6%) |
| June 2003 | - | -$28.98 M(+4.4%) |
| Mar 2003 | - | -$27.77 M(+3.9%) |
| Dec 2002 | -$26.74 M(+15.5%) | -$26.74 M(+3.6%) |
| Sept 2002 | - | -$25.81 M(+3.6%) |
| June 2002 | - | -$24.92 M(+3.7%) |
| Mar 2002 | - | -$24.03 M(+3.8%) |
| Dec 2001 | -$23.15 M(+15.9%) | -$23.15 M(+4.6%) |
| Sept 2001 | - | -$22.14 M(+3.5%) |
| June 2001 | - | -$21.39 M(+3.6%) |
| Mar 2001 | - | -$20.65 M(+3.3%) |
| Dec 2000 | -$19.98 M(+28.0%) | -$19.98 M(+5.4%) |
| Sept 2000 | - | -$18.95 M(+5.4%) |
| June 2000 | - | -$17.98 M(+7.6%) |
| Mar 2000 | - | -$16.71 M(+7.1%) |
| Dec 1999 | -$15.61 M(+27.3%) | -$15.61 M(+7.7%) |
| Sept 1999 | - | -$14.49 M(+7.1%) |
| June 1999 | - | -$13.53 M(+5.7%) |
| Mar 1999 | - | -$12.80 M(+4.5%) |
| Dec 1998 | -$12.26 M(+63.6%) | -$12.26 M(+16.4%) |
| Sept 1998 | - | -$10.53 M(+9.6%) |
| June 1998 | - | -$9.61 M(+8.0%) |
| Mar 1998 | - | -$8.89 M(+18.7%) |
| Dec 1997 | -$7.49 M | -$7.49 M(+8.6%) |
| Sept 1997 | - | -$6.90 M(+19.0%) |
| June 1997 | - | -$5.80 M |
FAQ
- What is Nymox Pharmaceutical annual retained earnings?
- What is the all time high annual retained earnings for Nymox Pharmaceutical?
- What is Nymox Pharmaceutical quarterly retained earnings?
- What is the all time high quarterly retained earnings for Nymox Pharmaceutical?
What is Nymox Pharmaceutical annual retained earnings?
The current annual retained earnings of NYMX is -$199.14 M
What is the all time high annual retained earnings for Nymox Pharmaceutical?
Nymox Pharmaceutical all-time high annual retained earnings is -$7.49 M
What is Nymox Pharmaceutical quarterly retained earnings?
The current quarterly retained earnings of NYMX is -$200.53 M
What is the all time high quarterly retained earnings for Nymox Pharmaceutical?
Nymox Pharmaceutical all-time high quarterly retained earnings is -$5.80 M